Medication info
Telmican Q Tablet 40/5/10/5 Milligrams

Telmican Q Tablet 40/5/10/5 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletRosuvastatin Calcium›5.2mg / 1 tabletEzetimibe›10mg / 1 tabletAmlodipine Besylate›6.944mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Yellow oval film-coated tablet
Packaging
30 tablets/box [6 tablets/PTP X 5]
Approval status
Active

MFDS item code 202203050 · Approved 2022.07.21 · Insurance code 645406160

Summary

Main use
Treatment of hypertension and dyslipidemia (hypercholesterolemia and mixed dyslipidemia)
Who takes it
Adults
Adult dose
This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water without regard to meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Take this medicine whole; do not chew, divide, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering the telmisartan/amlodipine combination; however, direct switching to the telmisartan/amlodipine combination may be considered if blood pressure is not controlled with the individual components, as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or the telmisartan/amlodipine combination 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin/ezetimibe Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dosage range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended starting dose is 5/10mg once daily. For patients requiring a greater reduction in LDL-cholesterol, the dose may be adjusted. After starting treatment with the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. For patients taking the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination concomitantly, switching to this medicine (a combination product containing the same amount of each active ingredient) may be considered for convenience.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and dyslipidemia (hypercholesterolemia and mixed dyslipidemia)

  • Essential hypertension
  • primary hypercholesterolemia
  • familial combined hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apolipoprotein B
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is suitable for patients suffering from both hypertension and dyslipidemia. First, the combination of telmisartan and amlodipine is used for essential hypertension patients for whom blood pressure control is difficult with monotherapy. Additionally, the combination of rosuvastatin and ezetimibe helps to improve blood cholesterol and lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. This medication provides an additional treatment option for patients who need to effectively control blood pressure and lipid levels while administering two main ingredients together. Therefore, this medication is recommended for those looking to manage both hypertension and dyslipidemia concurrently.

How to take

Adult dose

This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water without regard to meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Take this medicine whole; do not chew, divide, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering the telmisartan/amlodipine combination; however, direct switching to the telmisartan/amlodipine combination may be considered if blood pressure is not controlled with the individual components, as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or the telmisartan/amlodipine combination 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin/ezetimibe Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dosage range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended starting dose is 5/10mg once daily. For patients requiring a greater reduction in LDL-cholesterol, the dose may be adjusted. After starting treatment with the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. For patients taking the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination concomitantly, switching to this medicine (a combination product containing the same amount of each active ingredient) may be considered for convenience.

Precautions

This medication can pose a serious risk to the fetus during pregnancy, so women who are pregnant or may become pregnant should avoid taking it. Patients with certain liver and kidney diseases, muscle disorders, and those taking certain medications may experience exacerbated side effects, so caution is required. Before taking this medication, it is important to check for any history of allergic reactions or hypersensitivity; patients with impaired liver or kidney function should use it cautiously under a doctor's direction. This medication may cause muscle-related side effects such as myalgia, muscle weakness, or rhabdomyolysis, so patients should immediately inform their physician if any unusual symptoms arise in the muscles. As this medication lowers blood pressure, symptoms of hypotension (dizziness, fainting, etc.) may occur, and appropriate measures should be taken if such symptoms arise. During the use of this medication, it is important to regularly monitor liver function, kidney function, and blood potassium levels through blood tests. This medication can interact with various other drugs, so if any other medications are being taken, patients must inform their doctor or pharmacist. Additionally, while taking this medication, it is advisable to avoid excessive exercise or activities that put strain on the muscles, and to limit alcohol consumption. This medication may cause dizziness or drowsiness while driving or operating machinery, so caution is needed. If any allergic symptoms such as skin rash, swelling of the face or neck, or difficulty breathing develop after taking this medication, the treatment should be stopped immediately and medical advice sought.

Side effects

Eyelid damage, head injury, dysuria, flushing, chronic gastritis, various gastrointestinal disorders, hiatal hernia, chest pain, facial swelling, unusual sensations, drug intolerance, irritable bowel syndrome, esophagitis, dizziness, somnolence, neurodegenerative disorders, positional dizziness, migraine, diabetes, impaired glucose tolerance, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, cold sweats, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory disorders, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, upper respiratory tract infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal bloating, vomiting, abdominal discomfort, dry mouth, abnormal liver function, liver impairment, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, elevated serum creatine kinase, decreased hemoglobin, shock, loss of consciousness, interstitial pneumonia, rhabdomyolysis, palpitations, fatigue, nausea, insufficient effect, headache, facial spasms, sensory disturbances, paralysis, hyperventilation, pneumonia, flushing, erectile dysfunction, decreased appetite, edema, decreased libido, facial edema, conjunctivitis, tinnitus, petechiae, headache, cough, hyperventilation, pneumonia, weakness, lethargy, pain, weight gain, loss, vasculitis, hypertonia, sensory loss, sensory disturbances, peripheral neuropathy, taste disturbances, tremors, extrapyramidal disorders, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, dyspepsia, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, leukopenia, thrombocytopenia, insomnia, mood changes, rhinitis, alopecia, hyperhidrosis, purpura, skin discoloration, urticaria, tinnitus, visual disturbances, increased urinary frequency, urinary disturbances, nocturia, hepatitis, jaundice, elevated liver enzymes, pruritus, angioedema, erythema multiforme, myocardial infarction, arrhythmia, sinus block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, skin flushing, maculopapular rash, heaviness, warmth, impaired glucose tolerance, weakness, angioedema including hypersensitivity reactions, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, skeletal muscle effects, myopathy, rhabdomyolysis, immune-mediated necrotizing myopathy, elevated serum aminotransferases, elevated liver aminotransferases, anaphylaxis, urticaria, rash, angioedema, erythema multiforme, arthralgia, myalgia, elevated creatine phosphokinase, myopathy, rhabdomyolysis, elevated liver aminotransferases, hepatitis, abdominal pain, thrombocytopenia, nausea, pancreatitis, dizziness, sensory disturbances, depression, headache, cholelithiasis, cholecystitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Keeping the storage temperature between 1 and 30 degrees Celsius at room temperature is important to maintain the effectiveness and safety of the medication for a long time.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

30 tablets/box [6 tablets/PTP X 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.